{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:25:34Z","timestamp":1793892334661,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.diabres.2013.05.016","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T13:07:41Z","timestamp":1372165661000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: Preventive effects of metformin"],"prefix":"10.1016","volume":"101","author":[{"given":"Mar\u00eda Jos\u00e9","family":"Tolosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Roc\u00edo","family":"Chuguransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sedlinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le\u00f3n","family":"Schurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Desmond","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Silvina","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Mar\u00eda","family":"Cortizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2013.05.016_bib0005","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1055\/s-0030-1262825","article-title":"Diabetes and bone","volume":"42","author":"Pietschman","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.diabres.2013.05.016_bib0010","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/dc06-0440","article-title":"Prospective study of diabetes and risk of hip fracture The Nurses\u2019 Health Study","volume":"29","author":"Janghorbani","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2013.05.016_bib0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.diabres.2013.05.016_bib0020","doi-asserted-by":"crossref","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","article-title":"Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues","volume":"289","author":"Thrailkill","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.diabres.2013.05.016_bib0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00003086-198807000-00028","article-title":"The influence of diabetes mellitus on the healing of closed fractures","volume":"232","author":"Loder","year":"1988","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.diabres.2013.05.016_bib0030","doi-asserted-by":"crossref","first-page":"E1220","DOI":"10.1152\/ajpendo.00378.2011","article-title":"Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function","volume":"301","author":"Hamann","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.diabres.2013.05.016_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00011-010-0246-9","article-title":"Inflammation as death or life signal in diabetic fracture healing","volume":"60","author":"Roszer","year":"2011","journal-title":"Inflamm Res"},{"key":"10.1016\/j.diabres.2013.05.016_bib0040","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2337\/diabetes.52.6.1502","article-title":"A role for advanced glycation end products in diminished bone healing in type 1 diabetes","volume":"52","author":"Santana","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2013.05.016_bib0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00198-009-1066-z","article-title":"Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus","volume":"21","author":"Saito","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.diabres.2013.05.016_bib0050","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bone.2006.09.011","article-title":"Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways","volume":"40","author":"Alikhani","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.diabres.2013.05.016_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1024934008982","article-title":"Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK)","volume":"250","author":"Cortizo","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.diabres.2013.05.016_bib0060","first-page":"650","article-title":"Advanced glycation end products affect growth and function of osteoblasts","volume":"29","author":"Franke","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.diabres.2013.05.016_bib0065","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/A:1006816223292","article-title":"Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells","volume":"170","author":"McCarthy","year":"1997","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.diabres.2013.05.016_bib0070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2121-2-16","article-title":"Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress","volume":"2","author":"McCarthy","year":"2001","journal-title":"BMC Cell Biol"},{"key":"10.1016\/j.diabres.2013.05.016_bib0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s005920170007","article-title":"Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development","volume":"38","author":"McCarthy","year":"2001","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2013.05.016_bib0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11010-007-9557-8","article-title":"Regulation of advanced glycation end product (AGE) receptors and apoptosis by AGEs in osteoblast-like cells","volume":"306","author":"Mercer","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.diabres.2013.05.016_bib0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-2007-992786","article-title":"Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells","volume":"116","author":"Schurman","year":"2008","journal-title":"Exp Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2013.05.016_bib0090","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2741\/s185","article-title":"RAGE and its ligands in bone metabolism","volume":"3","author":"Zhou","year":"2011","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.diabres.2013.05.016_bib0095","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","article-title":"Skeletal remodeling in health and disease","volume":"13","author":"Zaidi","year":"2007","journal-title":"Nat Medicine"},{"key":"10.1016\/j.diabres.2013.05.016_bib0100","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/en.143.6.2376","article-title":"Divergent effects of selective peroxisome proliferator-activated receptor \u03b32 ligands on adipocyte versus osteoblast differentiation","volume":"143","author":"Lecka\u2013Czernik","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabres.2013.05.016_bib0105","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1210\/en.2004-1677","article-title":"Increased bone adiposity and peroxisome proliferator-activated receptor-\u03b32 in type 1 diabetic mice","volume":"146","author":"Botolin","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabres.2013.05.016_bib0110","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/en.2004-0735","article-title":"Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation","volume":"146","author":"Ali","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabres.2013.05.016_bib0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/en.2003-0746","article-title":"Bone is a target for the antidiabetic compound rosiglitazone","volume":"145","author":"Rzonca","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabres.2013.05.016_bib0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejphar.2006.02.030","article-title":"Osteogenicactions of the anti-diabetic drug metformin on osteoblasts in culture","volume":"536","author":"Cortizo","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.diabres.2013.05.016_bib0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1359\/jbmr.090732","article-title":"Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies","volume":"25","author":"Molinuevo","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.diabres.2013.05.016_bib0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1464-5491.2012.03744.x","article-title":"Potential role of non-insulin adjunct therapy in Type 1 diabetes","volume":"30","author":"George","year":"2013","journal-title":"Diabetic Med"},{"key":"10.1016\/j.diabres.2013.05.016_bib0135","series-title":"The Biological Council of Animal Research, Welfare Panel. Guide for the Care and Use of Laboratory Animals: Eighth Edition","author":"Guidelines on Handling and Training of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.diabres.2013.05.016_bib0140","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1742-7843.2008.00321.x","article-title":"Hypoglycaemic effects of antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic rats","volume":"103","author":"Tamara","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.diabres.2013.05.016_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1166\/jbt.2012.1039","article-title":"Effect of surface topography of collagen scaffolds on Cytotoxicity and osteoblast differentiation","volume":"2","author":"Cortizo","year":"2012","journal-title":"J Biomater Tissue Eng"},{"key":"10.1016\/j.diabres.2013.05.016_bib0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1016\/j.diabres.2013.05.016_bib0155","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural protein during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.diabres.2013.05.016_bib0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4239\/wjd.v2.i3.41","article-title":"Osteoporosis in diabetes mellitus: possible cellular and molecular mechanisms","volume":"15","author":"Wongdee","year":"2011","journal-title":"World J Diabetes"},{"key":"10.1016\/j.diabres.2013.05.016_bib0165","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1016\/j.fct.2012.08.012","article-title":"The methanolic fraction of centratherum anthelminticum seed downregulates pro-inflammatory cytokines, oxidative stress, and hyperglycemia in STZ-nicotinamide-induced type 2 diabetic rats","volume":"50","author":"Arya","year":"2012","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.diabres.2013.05.016_bib0170","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1359\/jbmr.090316","article-title":"Type 1 diabetes in young rats leads to progressive trabecular bone loss, cessation of cortical bone growth, and diminished whole bone strength and fatigue life","volume":"24","author":"Silva","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.diabres.2013.05.016_bib0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.coph.2004.03.002","article-title":"Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications","volume":"4","author":"Nuttall","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.diabres.2013.05.016_bib0180","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bone.2010.12.016","article-title":"Increasing duration of type 1 diabetes perturbs the strength-structure relationship and increases brittleness of bone","volume":"48","author":"Nyman","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.diabres.2013.05.016_bib0185","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bone.2008.12.012","article-title":"Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis","volume":"44","author":"Kawashima","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.diabres.2013.05.016_bib0190","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1359\/jbmr.070115","article-title":"Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity","volume":"22","author":"Kayal","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.diabres.2013.05.016_bib0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11914-007-0007-z","article-title":"The biology of osteocytes","volume":"5","author":"Kogianni","year":"2007","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.diabres.2013.05.016_bib0200","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.febslet.2010.05.047","article-title":"Alterations of the Wnt\/beta-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormone-related protein in bone from diabetic mice","volume":"584","author":"Portal-N\u00fa\u00f1ez","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.diabres.2013.05.016_bib0205","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/jcb.21572","article-title":"Is HMGB1 an osteocyte alarmin?","volume":"103","author":"Bidwell","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.diabres.2013.05.016_bib0210","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/er.2009-0024","article-title":"From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis","volume":"31","author":"Manolagas","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabres.2013.05.016_bib0215","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/15209150050025230","article-title":"Metformin: intrinsic vasculoprotective properties","volume":"2","author":"Wiernsperger","year":"2000","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2013.05.016_bib0220","doi-asserted-by":"crossref","first-page":"e3363","DOI":"10.1371\/journal.pone.0003363","article-title":"Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study","volume":"3","author":"Lund","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2013.05.016_bib0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1463-1326.2006.00599.x","article-title":"The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being","volume":"9","author":"Moon","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2013.05.016_bib0230","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00125-009-1636-9","article-title":"The use of metformin in type 1 diabetes: a systematic review of efficacy","volume":"53","author":"Vella","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2013.05.016_bib0235","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/en.2002-220072","article-title":"Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation","volume":"144","author":"Lu","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabres.2013.05.016_bib0240","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1359\/JBMR.050514","article-title":"Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone","volume":"20","author":"Kume","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.diabres.2013.05.016_bib0245","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000281826","article-title":"Diabetes induced changes in rat mesenchymal stem cells","volume":"191","author":"Stolzing","year":"2010","journal-title":"Cells Tissues Org"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822713002210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822713002210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T07:43:05Z","timestamp":1645861385000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822713002210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0168822713002210"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2013.05.016","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: Preventive effects of metformin","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2013.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}